Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GKT137831 in type 2 diabetes and albuminuria
NCT02010242Phase 2Completed
- Sponsor
- Calliditas Therapeutics AB
- Start
- Oct 2013
- Primary completion
- Feb 2015
- Countries
- 6
01
Overview
A Phase 2 trial of setanaxib in diabetic nephropathy (DN), sponsored by Calliditas Therapeutics AB. Started Oct 2013; status: completed.
02
Drugs
setanaxib
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02010242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02010242.